Energy failure in multiple sclerosis and its investigation using MR techniques (Q33928808)

30 July 2017

1 reference

title

Energy failure in multiple sclerosis and its investigation using MR techniques (English)

1 reference

Claudia Wheeler-Kingshott

30 July 2017

0 references

David Paling

1

0 references

Xavier Golay

object named as

Xavier Golay

series ordinal

2

0 references

object named as

Claudia Wheeler-Kingshott

series ordinal

3

0 references

David H. Miller

series ordinal

5

object named as

David Miller

1 reference

30 July 2017

Raju Kapoor

4

1 reference

30 July 2017

10 June 2011

1 reference

30 July 2017

1 reference

30 July 2017

258

1 reference

30 July 2017

12

1 reference

30 July 2017

2113-2127

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-011-6117-7

30 July 2017

0 references

cites work

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Pathogenesis of axonal and neuronal damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Enhanced number and activity of mitochondria in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Variations in mitochondrial DNA copy numbers in MS brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Mitochondrial changes within axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Mitochondrial defects in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Cerebrospinal fluid ATP metabolites in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

MR spectroscopy indicates diffuse multiple sclerosis activity during remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Canavan disease and the role of N-acetylaspartate in myelin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial brain imaging analysis of stroke-like episodes in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Prognostic value of proton magnetic resonance spectroscopy findings in near drowning patients: reversibility of the early metabolite abnormalities relates with a good outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

MR diffusion and perfusion parameters: relationship to metabolites in acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

(1)H-MRS profile in MRI positive- versus MRI negative patients with temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Relation between 1H MR spectroscopic imaging and regional cerebral glucose metabolism in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Changes in NAA and lactate following ischemic stroke: a serial MR spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Proton magnetic resonance spectroscopy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

MR correlates of cerebral atrophy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Imaging axonal damage of normal-appearing white matter in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

The human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Neuroimaging of mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Pathophysiology and long-term outcome of reversible tumor-like lesions induced by presenting status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial proton magnetic resonance spectroscopy in lesions of Balò concentric sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Dynamics of cerebral blood flow and metabolism in patients with cranioplasty as evaluated by 133Xe CT and 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Human focal cerebral ischemia: evaluation of brain pH and energy metabolism with P-31 NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Biochemical changes within a multiple sclerosis plaque in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Sodium magnetic resonance imaging: from research to clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Sodium imaging intensity increases with time after human ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Serial triple quantum sodium MRI during non-human primate focal brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Use of MRI to estimate the therapeutic window in acute stroke: is perfusion-weighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Toxicity of MRI and CT contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Measurement of cerebral perfusion territories using arterial spin labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Can arterial spin labeling detect white matter perfusion signal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Gray matter perfusion correlates with disease severity in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Assessment of thalamic perfusion in patients with mild traumatic brain injury by true FISP arterial spin labelling MR imaging at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Structural and metabolic changes in language areas linked to formal thought disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Abnormalities of cerebral perfusion in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Validation of oxygen extraction fraction measurement by qBOLD technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Imaging iron stores in the brain using magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Cerebral oxygen extraction fraction and cerebral venous blood volume measurements using MRI: effects of magnetic field variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Quantitative evaluation of oxygenation in venous vessels using T2-Relaxation-Under-Spin-Tagging MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Susceptibility-weighted imaging: clinical angiographic applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Chemical pathology of acute demyelinating lesions and its correlation with disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Deep Gray Matter Perfusion in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-011-6117-7

Conduction in segmentally demyelinated mammalian central axons

21 January 2018

1 reference

12 December 2020

Demyelination: the role of reactive oxygen and nitrogen species.

1 reference

12 December 2020

Three-dimensional triple-quantum-filtered (23)Na imaging of in vivo human brain

1 reference

12 December 2020

Examining lactate in severe TBI using proton magnetic resonance spectroscopy

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome

1 reference

12 December 2020

Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis.

1 reference

12 December 2020

Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis

1 reference

12 December 2020

Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with technetium-99m hexamethylpropyleneamine oxime

1 reference

12 December 2020

Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy.

1 reference

12 December 2020

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

1 reference

12 December 2020

Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo

1 reference

12 December 2020

Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging

1 reference

12 December 2020

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

1 reference

12 December 2020

"Absolute" quantification in magnetic resonance spectroscopy: validation of a clinical protocol in multiple sclerosis

1 reference

12 December 2020

CNS energy metabolism as related to function

1 reference

12 December 2020

Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

Biological aspects of sodium-23 imaging

1 reference

12 December 2020

Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity.

1 reference

12 December 2020

Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis

1 reference

12 December 2020

Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T

1 reference

12 December 2020

10.1007/S00415-011-6117-7

Identifiers

DOI

1 reference

PubMed ID

21660561

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

21660561